DONNA HEATH: Open Payments
NPI 1528375789 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,330 in 71 payments from 18 companies in 2025. Trend: 2023 $845 · 2024 $922 · 2025 $1,330
Food & beverage: $1,330
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 21 | $261 |
| AstraZeneca Pharmaceuticals LP | 10 | $192 |
| Merck Sharp & Dohme LLC | 4 | $107 |
| Actelion Pharmaceuticals US, Inc. | 4 | $96 |
| Regeneron Healthcare Solutions, Inc. | 5 | $90 |
| GENZYME CORPORATION | 3 | $81 |
| Insmed, Inc. | 3 | $79 |
| Verona Pharma, Inc. | 4 | $75 |
| Mallinckrodt Hospital Products Inc. | 2 | $59 |
| United Therapeutics Corporation | 2 | $59 |
Products named: NUCALA, DUPIXENT, OPSUMIT, Arikayce, Ohtuvayre, BREZTRI, TRELEGY ELLIPTA, ACTHAR.
Industry payments across TN — which companies pay providers there.
